Skip to main content
Premium Trial:

Request an Annual Quote

Play It Safe

The way grants are doled out leads researchers to play it safe -- and that's why there has been little progress in the "war on cancer," writes Gina Kolata in the New York Times. Incremental research is chosen by reviewers because "with too little money to finance most proposals, they are timid about taking chances on ones that might not succeed," Kolata writes.

At Respectful Insolence, Orac says that questioning whether the money was well-spent is fine, but that in the article. "Specifically, there is an unspoken assumption that 'riskier' research is inherently more likely to result in 'breakthroughs' than the more incremental model of building on previous results," Orac writes.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.